Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial Hypercholesterolemia
Clinical trial NCT04289285 · COMPLETED
Trial details
- NCT number
- NCT04289285
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2022-02-09
- Enrollment
- 804
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.